Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples